Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison.

Erder, M Haim

Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison. [electronic resource] - Applied health economics and health policy Nov 2012 - 381-95 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

1179-1896

10.1007/BF03261873 doi


Adolescent
Adrenergic Uptake Inhibitors--economics
Adrenergic alpha-2 Receptor Agonists--economics
Atomoxetine Hydrochloride
Attention Deficit Disorder with Hyperactivity--drug therapy
Child
Cost-Benefit Analysis
Delayed-Action Preparations
Female
Guanfacine--economics
Humans
Male
Markov Chains
Propylamines--economics
Quality-Adjusted Life Years
Treatment Outcome